Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/14/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. R. Dean Hautamaki

Wrong Dr. R. Dean Hautamaki?

Board Member

Phone: (510) ***-****  HQ Phone
WaferGen Biosystems Inc
7400 Paseo Padre Parkway
Fremont, California 94555
United States

Company Description: WaferGen Bio-systems, Inc. (WBSI) is engaged in the development, manufacture, and sale of systems for gene expression, genotyping, and stem-cell research for the...   more
Background

Employment History

Education

  • M.D.
  • University of Florida , College of Medicine
24 Total References
Web References
Board of Directors | Wafergen
www.wafergen.com, 14 Feb 2014 [cached]
R. Dean Hautamaki, M.D.
Director
Dr. Hautamaki has served as our director since the closing of the Merger. Dr. Hautamaki is a practicing physician and since January 2005 has been the Assistant Clinical Professor of Medicine at the Florida State University College of Medicine in Tallahassee, Florida. From September 2003 to December 2005, Dr. Hautamaki was the Chairman of the Department of Medicine at Sarasota Memorial Hospital in Sarasota, Florida. From September 1997 through December 2005, he was a partner at Lung Associates of Sarasota in Sarasota, Florida. Dr. Hautamaki has authored over 12 papers and presented in several conferences.
In addition, WaferGen named ...
www.biospace.com, 13 June 2007 [cached]
In addition, WaferGen named Joel Kanter and R. Dean Hautamaki, M.D. to the Board of Directors and Eugene A. Bauer M.D., to the position of Chairman of the company's Scientific Advisory Board.
...
R. Dean Hautamaki, M.D. is a practicing internist/pulmonary critical care specialist in Sarasota FL.Dr Hautamaki serves as an assistant clinical professor of medicine for Florida State University and is the principal investigator for over 40 clinical drug trials.Previously, he was Director of Critical Care Medicine as well as Chairman of Medicine at Sarasota Memorial Hospital.He graduated Alpha Omega Alpha from the University of Florida, College of Medicine and completed his residency and fellowship at Washington University School of Medicine in St Louis, MO.He has authored numerous articles and has lectured throughout the country on pulmonary disease.
...
Dr. Bauer was previously Vice President for Medical Affairs of Stanford University, Dean of the School of Medicine and was Chair of the Department of Dermatology.
Internet Wire MedicalHealth News
www1.internetwire.com, 23 May 2001 [cached]
AECB is a recurring , debilitating condition , and patients want to get better as quickly as possible , said Dean Hautamaki , MD , lead author of the study and Associate Director of Clinical Studies , Lung Associates of Sarasota and Director of Critical Care Services at Sarasota Memorial Hospital.Our findings are good news to both patients and physicians because they show that moxifloxacin effectively treats AECB in just five days , quicker than the approved courses of levofloxacin and other fluoroquinolones , which range from seven to ten days , he said.He added that the study is the first to directly compare moxifloxacin with levofloxacin for the treatment of AECB.
Study and Findings
The multicenter study employed a prospective , double-blind design to randomly assign adult patients confirmed with AECB to once-daily oral therapy of either moxifloxacin ( 400 mg ) for five days or levofloxacin ( 500 mg ) for seven days.The primary outcome was clinical response at the test-of-cure visit 7 to 21 days after therapy ended ; bacteriological responses were also assessed as a secondary measure.
Among patients who completed the study and were valid for efficacy analysis , the clinical cure rates of those given moxifloxacin ( 227 total ) and levofloxacin ( 234 total ) were statistically equivalent : 93 percent and 94 percent , respectively.
...
www.sec.gov, 3 April 2013 [cached]
0001435644 Hautamaki R Dean C/O WAFERGEN BIO-SYSTEMS, INC. 7400 PASEO PADRE PARKWAY FREMONT CA 94555 1 0 0 0
...
www.sec.gov, 20 June 2011 [cached]
0001435644 Hautamaki R Dean C/O WAFERGEN BIO-SYSTEMS, INC. 7400 PASEO PADRE PARKWAY FREMONT CA 94555 1 0 0 0
Other People with the name "Hautamaki":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304